Multiple sclerosis and pregnancy- treatment considerations
نویسندگان
چکیده
منابع مشابه
Multiple Sclerosis and Pregnancy: Current Considerations
Multiple sclerosis is the most common neurological disease of young adults that causes major disability. In Romania, it is estimated that this disease has a prevalence of 35-40 per 100,000 inhabitants. It is a disease that begins at the age of 20-40 years and is 2-3 times more common in women than in men. More than half of patients with MS develop the disease in their fertile period of life; th...
متن کاملPregnancy and multiple sclerosis.
At any one time, there are around 20 000 women of childbearing age with multiple sclerosis (MS) in the UK who may be considering having children. Neurologists can be asked for information from both patients and obstetric colleagues on a range of topics related to pregnancy and MS that extend beyond the well-known implications for relapse risk. This article aims to provide a brief overview for t...
متن کاملMultiple sclerosis and pregnancy.
Multiple sclerosis causes disability in young adults and, like most autoimmune diseases, affects women more commonly than men. The disease can therefore present at a time when many have, or are considering, starting a family. The effect of pregnancy on the outcome of multiple sclerosis is reviewed and the management of pregnant women who have multiple sclerosis is discussed.
متن کاملConsiderations on discontinuing natalizumab for the treatment of multiple sclerosis.
published by admin on Mon, 08/19/2013 3:11pm Title Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Publication Type Journal Article Year of Publication 2010 Authors Berger, JR, Centonze, D, Comi, G, Confavreux, C, Cutter, G, Giovannoni, G, Gold, R, Hartung, H-P, Lublin, F, Miravalle, A, Montalban, X, O'Connor, P, Olsson, T, Polman, CH, Stüve, O, Wolinsky, JS...
متن کاملBiomarker efficacy in multiple sclerosis diagnosis and treatment
The goal in studies concerning biomarkers in autoimmune diseases is finding a marker which fluctuates in correlation with the disease’s severity and settles within normal borders after effective treatment. This marker would later be used as an efficient tool in diagnosis and analysis of medicine clout. It seems the most cogent biomarkers are those measurable in serum or plasma. MS is a neurolog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pre-Clinical and Clinical Research
سال: 2020
ISSN: 1898-2395,1898-7516
DOI: 10.26444/jpccr/127671